Camden National Corporation’s Abbott ABT Stock Holding History

Camden National Corporation’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$918K	Buy	+7,657	New	+$907K	0.18%	71

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Camden National Corporation's ABT Position: Q1 2021 in Review

Camden National Corporation opened a new position in Abbott (ABT) in Q1 2021: 7,657 shares worth $918K. The stake represents 0.18% of the portfolio and ranks #71 among its holdings.

2,524 funds tracked by Wall St. Rank hold ABT as of Q1 2021.

Camden National Corporation held 7,657 shares of Abbott worth $918K as of Q1 2021.
Abbott was a new Camden National Corporation position in Q1 2021.
Abbott made up 0.18% of Camden National Corporation's portfolio in Q1 2021, its #71 holding.
2,524 funds tracked by Wall St. Rank held Abbott as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.